Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
American Journal of Therapeutics(5)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(3)
Fisiología humana(3)
Salud y seguridad personal(2)
Medicina y salud(1)
Área de conocimiento
Bioquímica(1)
Enfermedad cardiovascular(1)
Epidemiología(1)
Farmacología(1)
Fisiología(1)
Origen
scopus(5)
An elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusHaemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction
ArticleAbstract: Leptin is a 167 aminoacid peptidic hormone secreted by adipose tissue. It works mainly in the hypothPalabras claves:C reactive protein, Hypertension, leptin, Nitric oxide, Type 2 Diabetes mellitusAutores:Cano R.A., Contreras F., Fouillioux C., González M.C., Gotera D., Lares M., Magaldi L., Mayda C.L., Pacheco B., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Luti Y., Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopus